Journal article
In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Diagnostic microbiology and infectious disease, Vol.26(1), pp.39-42
1996
DOI: 10.1016/S0732-8893(96)00173-3
PMID: 8950528
Abstract
Sanfetrinem, formerly GV104326, is a new trinem antimicrobial agent with extensive in vitro activity for a variety of different bacteria. The activity of sanfetrinem was determined using a broth microdilution MIC method versus a large number of clinical isolates of
Streptococcus pneumoniae, Haemophilus influenzae, and
Moraxella catarrhalis obtained in a recent 30-center United States surveillance study. The sanfetrinem MIC
50 and MIC
90 values for these three organism groups were 0.015 and 0.5 μg/ml, 0.25, and 0.5 μg/ml, and 0.015 and 0.03, respectively.
Details
- Title: Subtitle
- In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
- Creators
- Gary V DoernGary PierceAngela B Brueggemann
- Resource Type
- Journal article
- Publication Details
- Diagnostic microbiology and infectious disease, Vol.26(1), pp.39-42
- Publisher
- Elsevier Inc
- DOI
- 10.1016/S0732-8893(96)00173-3
- PMID
- 8950528
- ISSN
- 0732-8893
- eISSN
- 1879-0070
- Language
- English
- Date published
- 1996
- Academic Unit
- Epidemiology; Pathology; Health and Human Physiology; Internal Medicine
- Record Identifier
- 9984002315702771
Metrics
20 Record Views